Phage Based Diagnostics

01359 231856

Twitter Youtube Linkedin Envelope
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us
Menu
  • Home
  • About
    • About PBD Biotech
    • Industry Awards
    • Management Team
    • International
  • Actiphage
    • About Actiphage
    • Benefits of Actiphage
    • Rapid detection of mycobacterial disease
  • Bovine
    • Bovine TB
    • Johne’s Disease
    • Dairy Industry
  • Latest
    • Articles
    • Events
  • Case Studies
  • Research
  • Contact
    • Product Order Form
    • Contacting us

Dr Cath Rees to present at the International Conference on Food Microbiology in Birmingham

Dr Catherine Rees presented a talk at the International Conference on Food Microbiology 2016: 'Detection of viable Mycobacteria in milk and milk products – implications for the dairy industry and human health'.
Dr Cath Rees

The introduction of routine pasteurisation of milk and a TB eradication program resulted in a dramatic reduction in the number of cases of human TB in the UK, from more than 50,000 cases per annum in the 1940s to less than 50 cases of human Mycobacterium bovis infections being reported per annumn since the 1990s.

However there are many reports of viable Mycobacterium paratuberculosis (MAP) being detected in retail milk and milk products, indicating that this group of bacteria can survive commercial pasteurisation. Although not a recognised zoonotic organism, an association has been established between MAP and the development of Crohn’s disease, and regulatory bodies have advised that MAP should be eradicated from the food chain on a precautionary principle.

We have developed a method to rapidly and sensitively detect pathogenic mycobacteria in milk and have showed it can be used to detect viable MAP in milk products, including powdered infant formula. We have been working with raw milk cheese producers to develop methods to detect M. bovis in raw milk to ensure the safety of their products.

Given increasing consumer interest in the consumption of raw milk, and the resurgence of bovine TB in the UK, these methods will provide new ways to allow quality assurance tests to be performed. I will review the work that we have carried out and also discuss how this technique can also be used to develop new approaches to eradicate these endemic diseases from diary cattle to further improve food safety.

Share:
  • Events

Related posts

Loading...
See PBD Biotech at The Dairy Show

5 October 2022

See us at The Dairy Show

September 6, 2022
Ensuring consumer confidence in dairy products has never been more vital and we are delighted to have the opportunity to talk about our new blood test and bulk milk test with producers, cheesemakers, dairy companies and others across the industry...
See PBD Biotech at The Dairy Show

5 October 2022

See us at The Dairy Show

September 6, 2022
Ensuring consumer confidence in dairy products has never been more vital and we are delighted to have the opportunity to...
ICP 2022

12 -16th June 2022

ICP 2022

May 26, 2022
The role of Actiphage® as a powerful research tool for tuberculosis-related diseases is to be explored at the 15th International Association for Paratuberculosis Colloquium (ICP2022) in Dublin on 12 – 16th June 2022.
ICP 2022

12 -16th June 2022

ICP 2022

May 26, 2022
The role of Actiphage® as a powerful research tool for tuberculosis-related diseases is to be explored at the 15th International...
Cath Rees

21-23 August 2022

The Science of Artisan Cheese

May 25, 2022
Prof. Cath Rees CSO has spoken at the conference on several occasions and is delighted to be invited back to talk about developments in Actiphage, and its application to test milk for the presence of bTB and MAP.
Cath Rees

21-23 August 2022

The Science of Artisan Cheese

May 25, 2022
Prof. Cath Rees CSO has spoken at the conference on several occasions and is delighted to be invited back to...
ECCMID conference

23-26 April 2022

Novel TB diagnostics paper to be presented at ECCMID 2022

April 4, 2022
Jee-Whang Kim of Leicester Tuberculosis Research Group (LTBRG) is to present a paper in the ‘hot topics in tuberculosis’ session at ECCMID 2022
ECCMID conference

23-26 April 2022

Novel TB diagnostics paper to be presented at ECCMID 2022

April 4, 2022
Jee-Whang Kim of Leicester Tuberculosis Research Group (LTBRG) is to present a paper in the ‘hot topics in tuberculosis’ session...
1 2 … 4 Next »

developers of phage-based diagnostics

Contact Us

Registered Company Address
Grosvenor St Paul’s
Grosvenor House
11 St Paul’s Square
Birmingham
B3 1RB
United Kingdom

T: 01359 231856
info@pbdbio.com

Privacy and cookies policy

© 2022 PBD Biotech Ltd

design: out of house

  • Follow Us!
PBD Biotech

More reasons to invest in better diagnostics for #tuberculosis 1.6 million preventable deaths and increased pressure on the few treatments available. #EndTB

Read More
PBD Biotech

Delighted Dr Marie Roskrow is the new Chair @PBDBiotech to support development of our rapid TB diagnostic. A physician-scientist she brings expertise from @KinomicaLtd @ImevaX along with Patrys Limited, METALINEAR LIMITED, ArcticZymes Technologies

Read More
PBD Biotech

Testing 4 tuberculosis gained renewed attention in 2022 reports @360DxNews Highlighting $30m funding @UNITAID for @FINDdx also @PBDBiotech gaining $2.9M for its blood-based test to predict which individuals with latent TB will progress to active disease

Read More